<DOC>
	<DOCNO>NCT02216513</DOCNO>
	<brief_summary>The investigator test central hypothesis DFO treatment SAH may improve cerebrovascular regulation , mitigate ischemic neural injury , serve effective neuroprotectant delay ischemic injury SAH .</brief_summary>
	<brief_title>Deferoxamine Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Subarachnoid Hemorrhage</mesh_term>
	<mesh_term>Brain Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Deferoxamine</mesh_term>
	<criteria>diagnosis spontaneous SAH impair cerebral autoregulation day 24 post SAH traumatic SAH central neurological disorder tumor , know prior stroke , hemorrhage vascular malformation pregnancy severe renal disease anuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>subarachnoid hemorrhage</keyword>
	<keyword>SAH</keyword>
	<keyword>DFO</keyword>
	<keyword>cerebral autoregulation</keyword>
	<keyword>delay cerebral ischemia</keyword>
</DOC>